Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Illumina to Genotype SNPs for Placer

NEW YORK, May 3 - Private biotech firm Placer has chosen Illumina to provide SNP-genotyping services.

 

The deal, announced yesterday evening, calls for Illumina to use its BeadArray technology to genotype SNPs thought to be linked with psoriasis and other skin conditions. The firm will also design assays for the SNP loci.

The deal comes one week after Illumina penned a similar deal with the Laboratory of Psychiatric Genomics at the University of California, San Diego.

Click here for more information about the Placer agreement.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.